Freeline Therapeutics Holdings plc Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Freeline Therapeutics Holdings plc reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$440.00 thousand for the 9-month period ending 2023-09-30, per its 6-K filed 2023-12-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2023-12-01
- Freeline Therapeutics Holdings plc increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2023-09-30 was -$1.32M, a 139.79% decline year-over-year.
- Freeline Therapeutics Holdings plc increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2023-06-30 was $1.30M.
- Freeline Therapeutics Holdings plc increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2023-03-31 was -$423.00K.
- Freeline Therapeutics Holdings plc increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2022-12-31 was -$1.01M, a 131.31% decline year-over-year.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$1.32M derived: 6-K 9 month − 6-K 6 month · filed 2023-12-01 | -$17.00K derived: sum of 2 quarters · filed 2023-12-01 | -$440.00K 6-K · filed 2023-12-01 | -$1.45M derived: sum of 4 quarters · filed 2023-12-01 |
| 2023-06-30 | $1.30M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | $879.00K 6-K · filed 2023-08-15 | -$135.00K derived: sum of 3 quarters · filed 2023-08-15 | $3.18M derived: sum of 4 quarters · filed 2023-12-01 |
| 2023-03-31 | -$423.00K 6-K · filed 2023-05-30 | -$1.44M derived: sum of 2 quarters · filed 2023-05-30 | $1.88M derived: sum of 3 quarters · filed 2023-12-01 | $866.00K derived: sum of 4 quarters · filed 2023-12-01 |
| 2022-12-31 | -$1.01M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | $2.30M derived: sum of 2 quarters · filed 2023-12-01 | $1.29M derived: sum of 3 quarters · filed 2023-12-01 | -$5.12M 20-F · filed 2023-04-04 |
| 2022-09-30 | $3.31M derived: 6-K 9 month − 6-K 6 month · filed 2023-12-01 | $2.30M derived: sum of 2 quarters · filed 2023-12-01 | -$4.11M 6-K · filed 2023-12-01 | -$871.00K derived: sum of 4 quarters · filed 2023-12-01 |
| 2022-06-30 | -$1.01M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | -$7.42M 6-K · filed 2023-08-15 | -$4.19M derived: sum of 3 quarters · filed 2023-08-15 | -$2.46M derived: sum of 4 quarters · filed 2023-08-15 |
| 2022-03-31 | -$6.41M 6-K · filed 2023-05-30 | -$3.17M derived: sum of 2 quarters · filed 2023-05-30 | -$1.44M derived: sum of 3 quarters · filed 2023-05-30 | -$961.00K derived: sum of 4 quarters · filed 2023-05-30 |
| 2021-12-31 | $3.24M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | $4.97M derived: sum of 2 quarters · filed 2023-04-04 | $5.45M derived: sum of 3 quarters · filed 2023-04-04 | $5.01M 20-F · filed 2023-04-04 |
| 2021-09-30 | $1.73M derived: 6-K 9 month − 6-K 6 month · filed 2022-11-15 | $2.21M derived: sum of 2 quarters · filed 2022-11-15 | $1.77M 6-K · filed 2022-11-15 | $1.17M derived: sum of 4 quarters · filed 2023-04-04 |
| 2021-06-30 | $482.00K derived: 6-K 6 month − 6-K 3 month · filed 2022-08-09 | $38.00K 6-K · filed 2022-08-09 | -$562.00K derived: sum of 3 quarters · filed 2023-04-04 | $1.32M derived: sum of 4 quarters · filed 2023-04-04 |
| 2021-03-31 | -$444.00K 6-K · filed 2022-05-10 | -$1.04M derived: sum of 2 quarters · filed 2023-04-04 | $837.00K derived: sum of 3 quarters · filed 2023-04-04 | $1.46M derived: sum of 4 quarters · filed 2023-04-04 |
| 2020-12-31 | -$600.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | $1.28M derived: sum of 2 quarters · filed 2023-04-04 | $1.90M derived: sum of 3 quarters · filed 2023-04-04 | $3.65M 20-F · filed 2023-04-04 |
| 2020-09-30 | $1.88M derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09 | $2.50M derived: sum of 2 quarters · filed 2021-11-09 | $4.25M 6-K · filed 2021-11-09 | |
| 2020-06-30 | $622.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-08-16 | $2.37M 6-K · filed 2021-08-16 | ||
| 2020-03-31 | $1.75M 6-K · filed 2021-05-17 | |||
| 2019-12-31 | -$1.09M 20-F · filed 2022-03-31 | |||
| 2019-06-30 | -$835.00K 6-K · filed 2020-10-29 | |||
| 2018-12-31 | $6.22M 20-F · filed 2021-03-31 |